Which antipsychotic works best for lewy body psychosis? new trial aims to find out
NCT ID NCT05590637
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study compares two antipsychotic drugs, pimavanserin and quetiapine, to see which one better reduces hallucinations and delusions in people with Parkinson's disease or dementia with Lewy bodies. About 94 participants will be randomly assigned to one of the two medications, and their symptoms will be tracked using a standard questionnaire. The goal is to provide real-world guidance for doctors choosing between these treatments.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- pimavanserin (Nuplazid) and quetiapine (Seroquel)
- What this could lead to
- If it works, this could help doctors choose the best antipsychotic for managing hallucinations and delusions in people with Lewy body disease.
- What could go wrong
- This is a small, early-phase trial with only 94 participants, so results may not apply to everyone. Both drugs have known side effects, and the study compares existing treatments, not a new breakthrough.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UT Health Science Center - San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
University Health System
RECRUITINGSan Antonio, Texas, 78229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Skin, speech, and brain scans may unmask hidden neurodegeneration
- Can sound waves soothe Dementia's emotional turmoil?
- Cancer drug shows promise for treating lewy body dementia
- Could tiny doses of radiation slow Alzheimer's? a new trial investigates
- Brain scans track Alzheimer's clues over decades
- Can a One-Time bone drug shield Parkinson's patients from fractures?